Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

CBITS-RTM Pilot Study

2. juli 2026 opdateret af: University of California, San Francisco

Preventing Substance Use Among Incarcerated Youth Through Addressing Posttraumatic Stress

This pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.

Studieoversigt

Detaljeret beskrivelse

The study examines the intervention's feasibility and acceptability, as well as its effectiveness in reducing incarcerated youth's posttraumatic stress symptoms, improving academic functioning, and decreasing intentions to use substances post-release.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

28

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • California
      • San Francisco, California, Forenede Stater, 94131
        • UCSF Zuckerberg San Francisco General Hospital
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Youth must 1) be currently incarcerated in a partnering juvenile detention center, 2) be between 13-18 years of age, and 3) have a minimum of 3 months remaining on their sentence (i.e., sufficient time required to complete CBITS-RTM). Youth will complete a screening with a study team member involving the 2-item Abbreviated PTSD Checklist-Civilian version, with scores ≥4 considered a positive screen
  • Clinicians are eligible if they are behavioral health staff working with youth at the detention school..

Exclusion Criteria:

  • Observable cognitive or developmental delays or active psychosis that would interfere with completing consent, assessment or intervention.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Adapted CBITS-RTM Intervention
The Cognitive Behavioral Intervention for Trauma in Schools (CBITS) program is a school-based, group and individual intervention designed to reduce symptoms of post-traumatic stress disorder (PTSD), depression, and behavioral problems, and to improve functioning, grades and attendance, and coping skills. The CBITS intervention was adapted to juvenile justice settings with an added Racial Trauma Module (RTM), which provides youth with an overview of the effects of racism on levels of traumatic stress.
Andre navne:
  • CBITS-RTM

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Child PTSD Symptom Scale (CPSS)
Tidsramme: Baseline, 3 months post-baseline
The CPSS is used to measure posttraumatic stress among youth (8-18 years). It assesses past month posttraumatic stress symptom severity and impairment of endorsed symptoms on daily functioning. Scores range from 0-80, with 31+ indicating probable PTSD.
Baseline, 3 months post-baseline

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Youth Alcohol and Drug Use Survey
Tidsramme: Baseline, 3 months post-baseline
The Youth Alcohol and Drug Use Survey will be used to gather youth's intention to use substances post-release using items rated on a scale from 1 (unlikely) to 10 (very likely).
Baseline, 3 months post-baseline
Texas Christian University (TCU) Drug Screen
Tidsramme: Baseline, 3-months post-baseline
The TCU will be administered to gather information on substance use quantity and frequency as well as risk for SUD (corresponds with DSM-5 criteria) on the 3-months prior to incarceration and past 3 months at post-release.
Baseline, 3-months post-baseline

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Youth Background Characteristics
Tidsramme: Baseline
Demographics questionnaire used to gather standard demographics (e.g., age, gender, race) and information such as state agency involvement (e.g., age at first contact with juvenile legal system, number of prior arrests), immigration status.
Baseline
Treatment Acceptability Form
Tidsramme: 3-months post-baseline
This form will be used to assess the acceptability of the adapted CBITS-RTM intervention. Items are scored from 1 "Strongly disagree" to 5 "Strongly agree." Scores range from 10-50 with higher scores indicating higher acceptability.
3-months post-baseline
CBITS-RTM Group Evaluation Posttest
Tidsramme: 3-months post-baseline
This will assess knowledge of trauma, changes in ability to cope with stress, and acceptability of the intervention and its delivery. Items are true/false or qualitative in nature.
3-months post-baseline
Clinician personal and professional background characteristics
Tidsramme: Baseline
Questionnaire used to gather personal and professional background characteristics (e.g., clinical discipline, experience with trauma treatment, years of practice in juvenile detention setting).
Baseline
Cognitive Behavioral Intervention for Trauma in Schools-Fidelity Adherence Measure 2.0
Tidsramme: 20% of the sessions
This measure will be used to assess how closely clinicians adhere to the adapted CBITS-RTM intervention. The scale describes the core components expected to be covered in each session, and the rater indicates the degree to which each component was delivered with fidelity using a 4-point item rating ranging from 0 (not covered at all) to 3 (covered thoroughly). Higher item scores indicate greater fidelity to the intervention curriculum.
20% of the sessions
The Evidence-Based Practice Attitude Scale (EBPAS)
Tidsramme: Baseline
The EBPAS (15-items) will be used to assess clinician's attitudes toward adopting new evidence-based practices (EBPs). It consists of four subscales: appeal, requirements, openness, and divergence. Items are rated on a 5-point Likert scale from 0 (not at all) to 4 (to a very great extent). Higher scores on the Appeal, Requirements, and Openness subscales indicate more positive attitudes toward adopting EBPs, whereas higher Divergence scores indicate less favorable attitudes.
Baseline

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Johanna Folk, PhD, University of California, San Francisco

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. september 2026

Primær færdiggørelse (Anslået)

30. juni 2027

Studieafslutning (Anslået)

31. december 2027

Datoer for studieregistrering

Først indsendt

26. juni 2026

Først indsendt, der opfyldte QC-kriterier

26. juni 2026

Først opslået (Faktiske)

2. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

6. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

2. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner